# PRSS48

## Overview
PRSS48 is a gene that encodes the protein serine protease 48, which is a member of the serine protease family. This family of proteins is characterized by the presence of a serine residue in their active site, which is crucial for their proteolytic activity. Serine protease 48 exhibits a trypsin-like fold, a structural motif common among serine proteases, and contains a catalytic triad composed of serine, histidine, and aspartate. These features are essential for its enzymatic function. The protein undergoes post-translational modifications such as glycosylation and phosphorylation, which may influence its stability and activity. PRSS48 is implicated in various biological processes, including male reproductive health, where it is considered a reproductive tract-specific enzyme, and has potential clinical significance in conditions such as hemophilia A and bovine respiratory diseases (Kiser2021Identifying; Robertson2020Largescale; Gorski2016Wholeexome).

## Structure
PRSS48, or serine protease 48, is a member of the serine protease family, characterized by a serine residue in its active site. This protein typically exhibits a trypsin-like fold, which is a common structural motif among serine proteases. The catalytic triad of PRSS48 consists of serine, histidine, and aspartate, which are essential for its enzymatic activity. 

Post-translational modifications of PRSS48 include glycosylation and phosphorylation, which may influence its stability, activity, and interactions. These modifications are typical for proteins in this family and can affect the protein's function and localization within the cell. 

Information on specific domains or isoforms of PRSS48 may vary, indicating potential diversity in its functional roles. However, detailed structural data on the primary, secondary, tertiary, and quaternary structures of PRSS48 are not provided in the available context. The presence of different splice variant isoforms could suggest functional versatility, but specific details are not mentioned. 

Overall, PRSS48 shares common structural and functional characteristics with other serine proteases, underscoring its role in proteolytic processes within the human body.

## Clinical Significance
The PRSS48 gene has been implicated in several clinical contexts. In the study of severe hemophilia A, a variant of PRSS48, rs2407221, was identified as a 'Stop lost' variant with a minor allele frequency of 3%. This variant is associated with a potential protective effect against inhibitor development in hemophilia A patients, as it is more frequent in non-inhibitor patients compared to inhibitor patients (Gorski2016Wholeexome).

In the context of male reproductive health, PRSS48 is identified as a novel reproductive tract-specific enzyme gene. Its specificity to the reproductive tract suggests potential as a target for drug development, particularly in male contraception, due to its low sequence similarity to non-reproductive tract-expressed paralogs, which minimizes the risk of off-target effects (Robertson2020Largescale).

Additionally, PRSS48 has been mentioned in studies related to bovine coronavirus infection and bovine respiratory disease, although its specific role in these conditions remains unclear (Kiser2021Identifying). The gene was also identified in a study involving a patient with LRBA deficiency, but its clinical significance in this context was not detailed (SolerPalacín2018LRBA).


## References


[1. (Kiser2021Identifying) Jennifer N. Kiser and Holly L. Neibergs. Identifying loci associated with bovine corona virus infection and bovine respiratory disease in dairy and feedlot cattle. Frontiers in Veterinary Science, August 2021. URL: http://dx.doi.org/10.3389/fvets.2021.679074, doi:10.3389/fvets.2021.679074. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fvets.2021.679074)

[2. (Robertson2020Largescale) Matthew J. Robertson, Katarzyna Kent, Nathan Tharp, Kaori Nozawa, Laura Dean, Michelle Mathew, Sandra L. Grimm, Zhifeng Yu, Christine Légaré, Yoshitaka Fujihara, Masahito Ikawa, Robert Sullivan, Cristian Coarfa, Martin M. Matzuk, and Thomas X. Garcia. Large-scale discovery of male reproductive tract-specific genes through analysis of rna-seq datasets. BMC Biology, August 2020. URL: http://dx.doi.org/10.1186/s12915-020-00826-z, doi:10.1186/s12915-020-00826-z. This article has 53 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1186/s12915-020-00826-z)

[3. (SolerPalacín2018LRBA) Pere Soler-Palacín, Marina Garcia-Prat, Andrea Martín-Nalda, Clara Franco-Jarava, Jacques G. Rivière, Alberto Plaja, Daniela Bezdan, Mattia Bosio, Mónica Martínez-Gallo, Stephan Ossowski, and Roger Colobran. Lrba deficiency in a patient with a novel homozygous mutation due to chromosome 4 segmental uniparental isodisomy. Frontiers in Immunology, October 2018. URL: http://dx.doi.org/10.3389/fimmu.2018.02397, doi:10.3389/fimmu.2018.02397. This article has 31 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fimmu.2018.02397)

[4. (Gorski2016Wholeexome) Marcin M. Gorski, Kevin Blighe, Luca A. Lotta, Emanuela Pappalardo, Isabella Garagiola, Ilaria Mancini, Maria Elisa Mancuso, Maria Rosaria Fasulo, Elena Santagostino, and Flora Peyvandi. Whole-exome sequencing to identify genetic risk variants underlying inhibitor development in severe hemophilia a patients. Blood, 127(23):2924–2933, June 2016. URL: http://dx.doi.org/10.1182/blood-2015-12-685735, doi:10.1182/blood-2015-12-685735. This article has 26 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1182/blood-2015-12-685735)